Invera Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$384K Buy
3,193
+3
+0.1% +$346 0.25% 81
2025
Q4
$336K Sell
3,190
-45
-1% -$4.22K 0.21% 80
2025
Q3
$272K Buy
+3,235
New +$266K 0.17% 79
2025
Q2
Sell
-9,327
Closed -$837K 91
2025
Q1
$837K Sell
9,327
-1,682
-15% -$157K 0.54% 63
2024
Q4
$1.06M Buy
11,009
+249
+2% +$25.7K 1.05% 27
2024
Q3
$1.09M Buy
10,760
+260
+2% +$30.9K 1.08% 27
2024
Q2
$1.35M Buy
10,500
+121
+1% +$15.6K 1.39% 24
2024
Q1
$1.3M Sell
10,379
-544
-5% -$67.1K 1.1% 34
2023
Q4
$1.19M Buy
+10,923
New +$1.13M 0.75% 43

Other funds holding MRK

Invera Wealth Advisors's MRK Position: Q1 2026 in Review

Invera Wealth Advisors increased its Merck (MRK) stake by 0.09% in Q1 2026, buying an estimated $346 and bringing the position to 3,193 shares worth $384K. The position accounts for 0.25% of the portfolio, ranked #81.

Invera Wealth Advisors first reported a position in MRK in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.35M in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Invera Wealth Advisors held 3,193 shares of Merck worth $384K as of Q1 2026.
  • Invera Wealth Advisors bought 3 Merck shares in Q1 2026, an estimated $346.
  • Merck made up 0.25% of Invera Wealth Advisors's portfolio in Q1 2026, its #81 holding.
  • Invera Wealth Advisors first reported a position in Merck in Q4 2023 and has held it in 9 quarters since.
  • Invera Wealth Advisors's Merck position peaked at $1.35M in Q2 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Invera Wealth Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.